Two-Drug attack tested against blood cancer
NCT ID NCT01446133
Summary
This study is testing whether combining two existing drugs, lenalidomide and rituximab, can help control chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is for adults who are either newly diagnosed and not candidates for standard chemo, or who have had prior treatment. The main goal is to see how well the combination works and to monitor its safety over multiple treatment cycles.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.